Identification of gene expression signatures for molecular classification in human leukemia cells

International Journal of Oncology

Volumn 29, Issue 1, 2006, Pages 57-64

  Song, Ju Han ^a   Kim, Hyeoung Joon ^a   Lee, Chang Hyun ^c   Kim, Seung Jun ^c   Hwang, Seung Yong ^c   Kim, Tae Sung ^a,b  

^a Chonnam National University   (South Korea)

^b Korea University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Classification; DNA microarray; Human; Leukemia; Marker

Indexed keywords

CD69 ANTIGEN; HHEX PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; LEUKOCYTE ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BONE MARROW CELL; CHEMISTRY; CHRONIC LYMPHATIC LEUKEMIA; CLASSIFICATION; CLUSTER ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOPSY; BONE MARROW CELLS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC MARKERS; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34248200709     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.1.57     Document Type: Article

References (27)

1. Harris NL, Jaffe ES, Diebold J, et al: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting 1997. J Clin Oncol 17: 3835-3849, 1999.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 33: 451-458, 1976.
3. Foon KA and Todd RF III: Immunologic classification of leukemia and lymphoma. Blood 68: 1-31, 1986.
4. Kalwinsky DK, Raimondi SC, Schell MJ, et al: Prognostic importance of cytogenetic subgroups in de novo pediatric acute non-lymphocytic leukemia. J Clin Oncol 8: 75-83, 1990.
5. Ma SK, Wan TS and Chan LC: Cytogenetics and molecular genetics of childhood leukemia. Hematol Oncol 17: 91-105, 1999.
6. Su AI, Welsh JB, Sapinoso LM, et al: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61: 7388-7393, 2001.
7. Ramaswamy S, Tamayo P, Rifkin R, et al: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98: 15149-15154, 2001.
8. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
9. Armstrong SA, Staunton JE, Silverman LB, et al: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47, 2002.
10. Valk PJ, Verhaak RG, Beijen MA, et al: Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350: 1617-1628, 2004.
11. Bullinger L, Dohner K, Bair E, et al: Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350: 1605-1616, 2004.
12. Yeoh EJ, Ross ME, Shurtleff SA, et al: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1: 133-143, 2002.
13. Ross ME, Mahfouz R, Onciu M, et al: Gene expression profiling of pediatric acute myelogenous leukemia. Blood 104: 3679-3687, 2004.
14. Boer JM, Huber WK, Sultmann H, et al: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500- element cDNA array. Genome Res 11: 1861-1870, 2001.
15. Song JH, Kim JM, Kim SH, et al: Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci 73: 1705-1719, 2003.
16. Bullinger L and Valk PJ: Gene expression profiling in acute myeloid leukemia. J Clin Oncol 23: 6296-6305, 2005.
17. Preisler HD: The leukemias. Dis Mon 40: 525-579, 1994.
18. Szer J: Current thinking in the management of leukaemia. Aust Fam Physician 23: 1500-1505, 1994.
19. Estilo CL, O-Charoenrat P, Ngai I, et al: The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res 9: 2300-2306, 2003.
20. Esplugues E, Sancho D, Vega-Ramos J, et al: Enhanced antitumor immunity in mice deficient in CD69. J Exp Med 197: 1093-1106, 2003.
21. 2, hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells. J Neurosci Res 76: 415-422, 2004.
22. Matthaei KI and Williams JF: Ornithine aminotransferase turnover in host tissues of tumor-bearing rats. J Natl Cancer Inst 79: 805-809, 1987.
23. Bellamy WT, Richter L, Frutiger Y and Grogan TM: Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 59: 728-733, 1999.
24. Ratajczak MZ, Ratajczak J, Machalinski B, et al: Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth. Br J Haematol 103: 969-979, 1998.
25. Lopes de Menezes DE, Peng J, Garrett EN, et al: CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia. Clin Cancer Res 11: 5281-5291, 2005.
26. Santin AD, Zhan F, Bignotti E, et al: Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 331: 269-291, 2005.
27. Witkowski JM, Zmuda-Trzebiatowska E, Swiercz JM, et al: Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood 100: 1802-1809, 2002.